{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T22:20:47Z","timestamp":1770502847386,"version":"3.49.0"},"reference-count":35,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2007,3,28]],"date-time":"2007-03-28T00:00:00Z","timestamp":1175040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2007,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Objective\u2002<\/jats:bold> To evaluate the efficacy of 5% imiquimod in HIV\u2010positive male patients with anogenital warts or anal intraepithelial neoplasia (AIN), and to elucidate whether human papillomavirus (HPV) type and viral load were important for clinical outcome and recurrences.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Thirty\u2010seven patients with histologically proven anogenital warts or AIN were enrolled. Topical 5% imiquimod was applied three times per week for more than 8\u00a0h overnight for 16\u00a0weeks, although patients were allowed to continue therapy for 4 more weeks if they did not have complete clearance of lesions.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Mean age was 34\u00a0years. The perianal area was the main lesion location. Thirty\u2010three patients had CD4 counts of &lt;\u00a0500\u00a0cells\/mm<jats:sup>3<\/jats:sup>. Eighteen patients had a histopathological diagnosis of AIN\u20101. Main HPV types detected corresponded to low\u2010risk HPV types. At 20\u00a0weeks of therapy, 46% patients achieved total clearance whereas 14 patients had &gt;\u00a050% clearance. Recurrence was observed in 5 of 17 patients who cleared. Clearance was not influenced by patients\u2019 CD4 counts, wart location, HIV viral load or HPV viral load.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> The assumption that visible perianal warts are benign lesions in HIV\u2010positive patients has to be reevaluated since an important number of such lesions could correspond to low\u2010grade anal disease, which in turn could progress to high\u2010grade anal disease or cancer. In addition, our results in this preliminary study indicate that imiquimod appears to be effective in treating AIN in HIV\u2010positive patients. Further studies are needed to document its utility to prevent high\u2010grade dysplasia and\/or anal cancer.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2007.02169.x","type":"journal-article","created":{"date-parts":[[2007,3,28]],"date-time":"2007-03-28T14:42:22Z","timestamp":1175092942000},"page":"1054-1060","source":"Crossref","is-referenced-by-count":51,"title":["Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV\u2010positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia"],"prefix":"10.1111","volume":"21","author":[{"given":"G","family":"Sanclemente","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SK","family":"Tyring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PL","family":"Rady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u2010J","family":"Zuleta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u2010A","family":"Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u2010C","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,8,2]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji163"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199301000-00007"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199805000-00011"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.75.3.172"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000181012.62385.4a"},{"key":"e_1_2_5_7_2","first-page":"216","article-title":"Anal condylomas in men. 1. Histopathological and virological assessment","volume":"65","author":"Syrjanen SM","year":"1989","journal-title":"Genitourin Med"},{"key":"e_1_2_5_8_2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2340\/0001555575470474","article-title":"Anal and penile condylomas in HIV\u2010negative and HIV\u2010positive men: clinical, histological and virological characteristics correlated to therapeutic outcome","volume":"75","author":"Von Krogh G","year":"1995","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000131335.15301.dd"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-200007000-00011"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199912030-00011"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200207050-00025"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.2.243"},{"key":"e_1_2_5_14_2","first-page":"463","article-title":"Dysplastic changes in the anal canal epithelium in minor surgical specimens","volume":"89","author":"Fenger C","year":"1981","journal-title":"Acta Pathol Microbiol Scand"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2004.08.007"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/82.18.1477"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-76-4-1057"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.1.357-361.2000"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-199203000-00002"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021641"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.74.5.349"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-199501000-00002"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/514194"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.11.026"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1086\/424599"},{"key":"e_1_2_5_26_2","first-page":"367","article-title":"Anal human papillomavirus DNA screening by Hybrid Capture II in human immunodeficiency virus\u2010positive patients with or without anal intercourse","volume":"13","author":"Drobacheff C","year":"2003","journal-title":"Eur J Dermatol"},{"key":"e_1_2_5_27_2","first-page":"424","article-title":"Papillomavirus\u2010induced anogenital lesions in 121 HIV seropositive men. Clinical, histological, viral study, and evolution","volume":"126","author":"Voltz JM","year":"1999","journal-title":"Ann Dermatol Venereol"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199804010-00005"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1258\/095646204322637191"},{"key":"e_1_2_5_30_2","unstructured":"WielandU WeissenbornS BrockmeyerNet\u00a0al.Imiquimod treatment of AIN of HIV positive men leads to a drop of HPV DNA loads along with clinical and histological regression. 22nd International Papillomavirus Conference 2\u20135 May 2005 Vancouver British Columbia Canada Poster X 04."},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.12.025"},{"key":"e_1_2_5_32_2","first-page":"377","article-title":"Detection of HPV in General ital condylomata: correlation between viral load and clinical outcome","volume":"20","author":"De Marco F","year":"2001","journal-title":"J Exp Clin Cancer Res"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1258\/0956462054944390"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-200203000-00001"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1177\/095646249500600210"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00181-2"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2007.02169.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2007.02169.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T19:11:53Z","timestamp":1696965113000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2007.02169.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,2]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["10.1111\/j.1468-3083.2007.02169.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2007.02169.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,2]]}}}